Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Coleman

Showing results (131-140 of 510) with videos related to

Pageof 51
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|August 14, 2019
Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuriaC I Coleman, E R Weeda, A Kharat, et al.
Journal of the American Dietetic Association|August 2, 2011
The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trialsHarm H H Feringa, Dayne A Laskey, Justine E Dickson, et al.
Journal of Medical Economics|May 16, 2012
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United StatesSoyon Lee, Daniel C Baxter, Brendan Limone, et al.
Translational Psychiatry|October 4, 2018
A polygenic p factor for major psychiatric disordersSaskia Selzam, Jonathan R I Coleman, Avshalom Caspi, et al.
Health and Quality of Life Outcomes|June 3, 2014
Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosisChristine G Kohn, Matthew F Sidovar, Kirandeep Kaur, et al.
The Lancet. Infectious Diseases|June 29, 2007
Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysisSachin A Shah, Stephen Sander, C Michael White, et al.
BMJ Open Diabetes Research & Care|December 5, 2019
Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USAMukul Singhal, Hiangkiat Tan, Craig I Coleman, et al.
Pharmacotherapy|April 1, 2018
Systematic Review and Meta-Analysis of Real-World Studies Evaluating Rivaroxaban for Cancer-Associated Venous ThrombosisBrandon K Martinez, Jit Sheth, Nishi Patel, et al.
Pharmacotherapy|March 27, 2016
Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation PatientsElaine Nguyen, Florence Egri, Elizabeth S Mearns, et al.
Journal of Fungi (Basel, Switzerland)|September 26, 2025
Healthcare Resource Utilization, Treatment Costs, and Mortality in Patients with Malignancies or Transplantation Who Develop Invasive AspergillosisThomas J Walsh, Craig I Coleman, Melissa Johnson, et al.
Pageof 51

Showing results (131-140 of 510) with videos related to

Sort By:
Pageof 51
Diabetic Medicine : a Journal of the British Diabetic Association|August 14, 2019
Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuriaC I Coleman, E R Weeda, A Kharat, et al.
Journal of the American Dietetic Association|August 2, 2011
The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trialsHarm H H Feringa, Dayne A Laskey, Justine E Dickson, et al.
Journal of Medical Economics|May 16, 2012
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United StatesSoyon Lee, Daniel C Baxter, Brendan Limone, et al.
Translational Psychiatry|October 4, 2018
A polygenic p factor for major psychiatric disordersSaskia Selzam, Jonathan R I Coleman, Avshalom Caspi, et al.
Health and Quality of Life Outcomes|June 3, 2014
Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosisChristine G Kohn, Matthew F Sidovar, Kirandeep Kaur, et al.
The Lancet. Infectious Diseases|June 29, 2007
Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysisSachin A Shah, Stephen Sander, C Michael White, et al.
BMJ Open Diabetes Research & Care|December 5, 2019
Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USAMukul Singhal, Hiangkiat Tan, Craig I Coleman, et al.
Pharmacotherapy|April 1, 2018
Systematic Review and Meta-Analysis of Real-World Studies Evaluating Rivaroxaban for Cancer-Associated Venous ThrombosisBrandon K Martinez, Jit Sheth, Nishi Patel, et al.
Pharmacotherapy|March 27, 2016
Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation PatientsElaine Nguyen, Florence Egri, Elizabeth S Mearns, et al.
Journal of Fungi (Basel, Switzerland)|September 26, 2025
Healthcare Resource Utilization, Treatment Costs, and Mortality in Patients with Malignancies or Transplantation Who Develop Invasive AspergillosisThomas J Walsh, Craig I Coleman, Melissa Johnson, et al.
Pageof 51